T-cell Therapy Prevents Multiple Virus Infections after Allo-HSCT
Updated 52-week follow-up data were presented at the EBMT meeting.
Tackling Storage and Logistical Challenges in Cell Therapy
The chief executive officer of Gamida Cell discussed upcoming research on 2 of their investigational agents, GDA-201 and omidubicel, for hematological malignancies.
Improving Bone Marrow Transplant With Omidubicel
The chief executive officer of Gamida Cell discussed the company's novel approach to cell proliferation.
